(Q54191456)

26 May 2018

title

A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. (English)

1 reference

26 May 2018

0 references

1 reference

Robbins KT

1

1 reference

26 May 2018

Vicario D

2

1 reference

26 May 2018

Seagren S

3

1 reference

26 May 2018

Weisman R

4

1 reference

26 May 2018

Pellitteri P

5

1 reference

26 May 2018

Kerber C

6

1 reference

26 May 2018

Orloff L

7

1 reference

26 May 2018

Los G

8

1 reference

26 May 2018

Howell SB

9

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 November 1994

1 reference

26 May 2018

The American Journal of Surgery

published in

1 reference

26 May 2018

volume

168

1 reference

26 May 2018

issue

5

1 reference

26 May 2018

page(s)

419-422

1 reference

26 May 2018

Head and neck cancer in 1994: a change in the standard of care

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

High-dose platinum for the treatment of refractory ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Very-high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

A critical evaluation of the principles governing the advantages of intra-arterial infusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2805%2980089-3

10.1016/S0002-9610(05)80089-3

7 January 2021

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018